Background. Focal segmental glomerulosclerosis (FSGS) is the most prevalent primary glomerulopathy in Brazil and its incidence is increasing worldwide. Pathogenesis is related to podocyte injury, which may be due to several factors including viruses, drugs, immunology. In 2004, the Columbia classification of FSGS identified five histologic variants of the disease: collapsing (COL), usual (not otherwise specified, NOS), tip lesion (TIP), perihilar (PHI) and cellular variant (CEL). Several studies have demonstrated molecular changes in podocytes of FSGS patients. This study sought to classify a large series of FSGS biopsies according to the Columbia classification and analyze the occurrence of immunohistochemical differences among the five variants.
Introduction
Focal segmental glomerulosclerosis (FSGS) is a clinical and pathological renal syndrome causing proteinuria, usually in the nephrotic range, and occurring predominantly in young individuals. According to several authors, the worldwide incidence of FSGS is on the rise annually, including in Brazilian statistics [1] [2] [3] . Data from the Paulista Registry of Glomerulopathies show that FSGS is the most common primary glomerulopathy in Brazil, accounting for 29.7% of cases, followed by membranous nephropathy (20.7%) and IgA nephropathy (17.8%) [4] . From an etiological standpoint, FSGS may be associated with a variety of conditions, including viral infections (HIV, SV40 and parvovirus B19), several drugs (heroin, pamidronate and interferon), hyperfiltration (as in hypertension, obesity and sickle-cell anemia), and genetic disorders (familiar forms) or may be idiopathic [5] . Podocyte injury is the core pathophysiological event of FSGS [6, 7] . Podocytes, or visceral epithelial cells, are highly differentiated glomerular cells that do not proliferate under normal conditions. Their molecular markers include nephrin, podocin, α-actinin-4, CD2-associated protein (CD2AP), podocalyxin, synaptopodin, WT1, CD10 (CALLA) and GLEPP-1. Some studies have found anomalous expression of these proteins in FSGS [8] [9] [10] . The Columbia classification for primary FSGS, first published by D'Agati et al. in 2004, proposed five mutually exclusive morphological variants of the disease (histologic criteria shown in Figure 1 ). These variants appear to be associated with distinct clinical characteristics and prognostic and therapeutic implications [11, 12] . Recognition of these variants through a combination of morphologic and molecular features may bring about a better understanding of the pathogenesis of FSGS and promote identification of new therapeutic targets. The present study sought to (i) classify cases of FSGS diagnosed at the Pathology Division of Hospital das Clínicas da Universidade de São Paulo (DAP-HC-FMUSP) into the collapsing (COL), cellular (CEL), not otherwise specified (NOS), tip (TIP) and perihilar (PHI) variants of the disease; and (ii) analyze on these the immunohistochemical expression of podocytes regarding to pedicel cytoskeleton and membrane structural molecules; podocyte differentiation and podocytes dedifferentiation markers.
Materials and methods

Selection of cases
All native consecutive kidney biopsy reports with an FSGS diagnosis received and processed at the DAP-HC-FMUSP from 1996 to 2006 were reviewed retrospectively for the diagnosis of primary FSGS. Patients were eligible for the study if they were older than 18 years, to avoid the inclusion of sclerosing lesions secondary to genetic disorders, and younger than 45 years at the time of renal biopsy, so that we could obtain a more representative sample of primary FSGS. Patients with secondary FSGS due to known etiology such as chronic pyelonephritis, hypertension, reflux nephropathy and HIV-seropositive were excluded from the study. Patients with FSGS in renal transplant biopsies were also excluded.
Renal biopsies containing <5 glomeruli per level of section in light microscopy were not included, as well as advanced stage of histologic chronicity (>90% of sclerotic glomeruli), insufficient tissue remnant in paraffin block for further study, biopsies with or without positive immunofluorescence for IgA and/or IgG in glomeruli. Patient charts were reviewed retrospectively for presenting laboratory findings at the time of biopsies.
Kidney biopsy specimens were routinely evaluated by light microscopy on Duboscq-Brasil-fixed, paraffin-embedded tissue using hematoxylin and eosin, periodic acid Schiff, Masson trichrome and methenamine silver staining; and by immunofluorescence microscopy in frozen tissue using fluoresceinated antibodies to immunoglobulins A, G and M, as well as complement fractions C3, C1q and fibrinogen. Selected FSGS patients based on the above criteria were entered into the registry. The archived renal biopsy slides were reanalyzed and blindly categorized by two nephropathologists (authors) according to the Columbia FSGS classification system (Figure 1 ). Discrepant classification was resolved by discussing the cases together.
Immunohistochemistry study
Renal biopsy sections (2 μm) were stained for the primary antibodies CD10, citokeratin 19 (CK19), citokeratin 8/18 (CK8/18), Vimentin and Ki-67 (Novocastra, Newcastle, UK), GLEPP-1 (Biogenex, San Ramon, CA), α-actinin-4 (Allexis biochemicals), WT1 (Dako Cytomation, Carpinteria, CA) and synaptopodin (Progen Biotechnick, Heidelberg, Germany). Antigen retrieval was performed by steaming on Dako Pascal for 35 min in 10-mM citrate buffer, pH 6.0. For synaptopodin, incubation with trypsin after steaming was used for additional antigen retrieval. Second generation Novolink (Novocastra, Newcastle, UK) polymers were used. Slides were eventually stained with hematoxylin and mounted with Entellan. Positive and negative controls included normal kidney from radical nephrectomies and normal transplant kidney biopsies performed routinely before graft implantation. Seven cases of membranous glomerulopathy biopsies were used as control for other proteinuric diseases. Germinal centers in palatine tonsillar tissue were used as Ki-67 control.
Immunohistochemistry analysis
Immunostaining was evaluated by light microscopy in a blinded fashion with focus on podocytes of glomerular lesions. Resident glomerular cells were identified by morphology and anatomical location. The following codes were applied for each primary antibody tested: (A) when the staining was positive in all glomeruli podocytes, including those of glomerular lesions; (B) when the marker was positive in normal glomeruli, but negative in podocytes of glomerular lesions; (C) when diffusely negative in all glomeruli and (D) when the antibody was positive only in podocytes of glomerular lesions, but negative in the other glomeruli. Unsatisfactory reactions for immunohistochemical analysis were assigned with Code E. The results were divided in markers of podocytes differentiation, markers of dedifferentiation and structural molecules of podocytes, such as pedicel cell membrane and cytoskeleton.
Statistics
Statistical analysis was performed using the chi-square test to compare FSGS variants according to the pattern of immunohistochemical staining for each primary antibody tested (Pattern codes A, B, C and D). For comparison purposes, cases were grouped in COL and non-COL in most of the tests. The unsatisfactory immunohistochemical reactions cases (Code E) were discarded from the tests. Statistical significance was assumed at P < 0.05.
Results
Morphologic classification
After application of the exclusion criteria, 131 eligible cases were assessed for the histologic criteria proposed by the Columbia classification that resulted in 50 cases of NOS variant (38.2%), 48 (36.6%) of COL, 19 (14.5%) of TIP, 9 (6.9%) of PHI and 5 (3.8%) of CEL ( Table 1) . The clinical characteristics of these cases at biopsy are summarized in Table 2 .
Immunohistochemistry
Seventeen specimens were inadequate for immunohistochemical staining due to scarce reminiscence tissue in the paraffin block so the final number submitted to immunohistochemistry was 114 cases, 43 of which classified as COL, 4 CEL, 42 NOS, 7 PHI and 18 TIP. Patterns and distribution of immunohistochemical markers sorted by differentiation-related, dedifferentiation-related and molecules of pedicel membrane and pedicel cytoskeleton are summarized in Tables 3-5 , respectively. Regarding the expression of immunohistochemical markers of podocyte differentiation, COL variant exhibited more frequent loss of CD10 and WT1 in glomerular lesions than the non-COL group (P = 0.004 and 0.002, respectively). Comparing COL and NOS separately, there was also a significant difference (P = 0.014) to the loss of CD10 expression, the same occurring with COL versus TIP (P = 0.004). The expression of WT-1 also revealed difference in COL versus NOS (P = 0.002) and COL versus TIP (P = 0.035). Vimentin failed to show significant differences in podocyte expression among the FSGS variants.
Similarly, the expression of dedifferentiation markers CK8-18 and CK19 were more common in the COL group than in the non-COL group (P = 0.014 and 0.008, respectively), except for Ki-67 that did not show significant differences (P = 0.098). However, the expression of Ki-67 was significantly more common in the COL and CEL group when compared with the NOS, TIP and PHI group (P = 0.016). We also observed differences when comparing the podocyte-like expression of CK8-18 in COL and NOS (P = 0.009), but not with COL versus TIP (P = 0.367). Similarly, comparisons to CK19 podocyte-like expression showed significant difference in COL versus NOS (P = 0.001), but not in COL versus TIP (P = 0.352).
Concerning the structural podocyte markers, we observed significantly reduced immunohistochemical expression of α-actinin-4 in the COL group when compared with the non-COL group (P = 0.019). There was significant difference also between COL and TIP separately (P = 0.002), but not between COL versus NOS (P = 0.105). Statistical comparisons among the variants to Synaptopodin and GLEPP-1 staining were not possible due to the great number of unsatisfactory reactions using these antibodies. We believed that these results were related to the age and fixation of tissues. We observed inconclusive reactions (Code E) in 21 (18.4%) cases with the antibody CD10; in 15 (13.2%) with Ki67; in 8 (7.0%) with CK8-18; in 15 (13.2%) with CK19; in 14 (12.3%) with Vimentin; in 14 (12.3%) with α-actinin-4; in 20 (17.5%) with WT-1; in 63 (55.3%) with GLEPP-1 and in 92 (80.7%) with synaptopodin. Variants CEL and PHI were not compared Comparison with other published series. Immunohistochemical expression of podocytes markers individually with other variants due to the low number of cases in this groups. Biopsies from normal kidneys resulted globally and diffusely positive on podocytes to α-actinin-4, CD10, GLEPP-1, Synaptopodin, Vimentin and WT-1. They resulted negative to Ki67, CK19 and CK8-18. All GNM biopsies stained identical to normal tissue controls ( Figure 2 ).
Discussion
Histologic classification
Increases in the number of patients with chronic kidney disease (CKD) have led to growing interest in a better understanding of the renal conditions involved in CKD, including FSGS. Improved knowledge of pathogenic mechanisms would allow development of individualized and more efficient therapeutic actions. The addition of new tools to the field of pathology has led to major advances in our understanding of pathogenic processes and, consequently, to the development of new histologic classifications. In primary FSGS, this has translated into recent recognition of the five variant forms of the disease, namely, the not otherwise specified (NOS), collapsing (COL), cellular (CEL), perihilar (PHI) and tip lesion (TIP) variants. It is now known that certain histologic features in FSGS are associated with poor clinical progression, including rapid deterioration of renal function and marked proteinuria [13] [14] [15] . Several studies have addressed the molecular aspects of glomerular disease, and have found that podocyte defects are implicated in the pathogenesis of FSGS [7, 16, 17] . Thus far, few studies have correlated the histologic variants of FSGS with immunohistochemical expression of podocyte proteins. This research pathway is essential if we are to gain an improved understanding of the pathophysiology of this condition, allowing identification of new diagnostic categories and distinct therapeutic approaches for each histologic variant.
The present series included 131 consecutive cases of primary FSGS diagnosed between 1996 and 2006, which were classified into the NOS, COL, TIP, PHI and CEL variants according to the Columbia classification criteria [11] . Of these, 50 (38.2%) were classified as NOS, 48 (36.6%) as COL, 19 (14.5%) as TIP, 9 (6.9%) as PHI and 5 (3.8%) as CEL ( Table 2) were TIP, 13% were COL, 26% were PHI and 3% were CEL [15] (Table 1) . It is unclear whether the authors included cases of glomerulosclerosis secondary to conditions such as hypertension or obesity, for instance. Our data revealed a higher prevalence of the COL variant, diverging from the above-cited case series, which we think to be related to socioeconomic status.
In the present study, lesions were most easily classified into the TIP, NOS or COL variants using the Columbia histologic criteria; there was substantial overlap of criteria for the NOS and PHI variant, as well as with COL and CEL variants. Some authors question the existence of a separate CEL variant, and claim it is merely a form of the COL variant [18] . Others agree that both variants are very difficult to distinguish histologically, if not impossible [19] . No clear clinical or prognostic differences between the two have been demonstrated by some authors, but common pathophysiological pathways affecting cell cycle regulatory proteins have been established [18, 19] . In our sample, there was overlap of histologic findings for both variants when the Columbia criteria were used for assessment [11, 12, 20] . In cases classified as COL, we found the coexistence of marked tubulointerstitial injury, sometimes with microcystic tubular dilatation. Although these changes are often present in the COL variant of FSGS, they may occur in other variants and even in other glomerulopathies, particularly in advanced chronic disease, although with no evidence of COL lesions or podocyte hyperplasia. Therefore, these tubulointerstitial findings should not be considered specific to COL variant FSGS, but might be of help in some differentials.
The distinction between the NOS and PHI variants also seemed unclear when using the current criteria. We believed the semiquantitative criterion varies according to the level of each histologic section. Some cases classified as FSGS (NOS) also exhibited concomitant PHI sclerosis and hyalinosis. According to the proposed criteria, the diagnosis of PHI variant FSGS should only be considered when over 50% of sclerotic glomeruli show hilar lesions; however, we found variation from one histologic section to another of a single biopsy. In some cases, we initially classified a specimen as NOS only to find PHI lesions after analysis of additional sections; this highlights the importance of representativeness to distinguish between the NOS and PHI variants. Failure to observe many histological sections, whether due to technical impossibility (as insufficient sample) or insufficient number of glomerular lesions, may lead to a mistaken diagnosis. Curiously, Stokes et al. (2006) did not include cases of the PHI variant in their series, as the authors believed that this variant often refers to secondary FSGS; however, they found evidence of PHI lesions in all other variants of the condition, except CEL [20] .
In our sample, the TIP variant was sometimes difficult to diagnose on histologic assessment when the apical lesion was represented marginally, with no apparent relation to the origin of the proximal convoluted tubule, and coexisted a confluence of hypertrophic podocytes, reactive parietal cells and tubular epithelial cells in a distorted glomerular tuft, giving it an overall aspect similar to that of COL injury. Likewise, in other biopsies, a confluence of endocapillary foam cells and leukocytes adjacent to the partially obscured urinary pole gave an aspect similar to that of CEL variant. A thorough search in several histologic sections for classic apical TIP in contact with the origin of the proximal tubule, as well as and the absence of other COL features, such as tubulointerstitial injury, is required to assist in differential diagnosis [20, 21] .
Immunohistochemical findings
In the present study, loss of α-actinin-4 expression in podocytes of injured glomerular segments was significantly more common in the COL variant when compared with other variants (P = 0.019). α-Actinin-4, an actin-filament cross-linking protein, is a cytoskeletal constituent of the secondary podocyte process. It plays a role in maintaining the mechanical stability and structural conformation of pedicels. α-Actinin-4 maintains connections to F-actin and myosin microfilaments, intermediate filaments and microtubules of the primary podocyte processes, transmembrane proteins of the filtration slit and proteins anchoring the pedicel to the glomerular basement membrane. These interactions enable transmission of the tensile forces occurring in the glomerular capillary to the pedicel [22] . Expression of α-actinin-4 occurs in the podocyte pedicel cytoplasm and mutations in the gene ACTN4, which codes for the protein, may lead to late-onset autosomal dominant FSGS [23] . Henderson et al. (2008) showed that ACTN4 knockout mice and in mice homozygous for mutations in this gene develop severe glomerulopathy with histologic changes similar to those found in COL FSGS. As its name implies, the COL variant of FSGS is histologically characterized by collapse of the glomerular tuft, and our data suggest that changes in α-actinin-4 in the podocyte cytoskeleton may be associated with the pathogenesis of this aspect of FSGS [24] . Loss of CD10 expression was also more frequent in injured glomerular segments of COL cases than in other variants (P = 0.004). This result is consistent with the existing literature and stresses the importance of better analysis of the role of this molecule in podocyte function. CD10 is also known as CALLA. Acquisition and/or loss of hematopoietic antigens has been reported at several stages of nephron growth and differentiation. Although some hematopoietic antigens (such as CD35) are expressed in a transient manner during embryogenesis, CD10 is maintained in the podocytes of mature glomeruli [16] . Barisoni et al. (1999) observed extensive loss of CD10 in COL FSGS and HIV-associated nephropathy (HIVAN), but could not replicate this finding in cases of GNM. Our findings revealed loss of WT-1 expression in injured glomerular segments, most frequently in cases of the COL variant (P = 0.002). The WT-1 protein is a gene transcription factor that plays a role in nephrogenesis and podocyte maturation. During kidney development, this protein is expressed in the induction of mesenchymal stem cells; it is later found in epithelial cells ( presumably podocytes) in the embryogenesis, and is finally restricted to podocytes in the mature glomerulus [8] . Several studies have shown that, in COL FSGS, podocytes cease to express WT-1 and begin to express molecules found only during embryogenesis instead [7, 25, 26] . Mutations in the WT1 gene are associated with genetic conditions such as Frasier syndrome and Denys-Drash syndrome, both of which are characterized by marked proteinuria and podocyte dedifferentiation [7] .
Neoexpression of CK8/18 and CK19 in podocytes was significantly more common in the COL variant of FSGS (P = 0.014 and 0.008, respectively) than in the other variants. This finding was detected in the injured glomerular segments, which is consistent with previous reports; some authors have interpreted this event as a consequence of the podocyte dedifferentiation that takes place in COL FSGS [7, 18, 27] . Podocyte dedifferentiationı that takes place over the course of COL FSGS has been well documented, and authors have described loss of podocyte maturity and regression to the cell cycle, loss of expression of cell maturation markers such as WT-1 and CD10 and loss of podocyte cytoskeleton markers such as synaptopodin [17, 27] . The present study reinforces this theory, showing that podocyte dedifferentiation in the COL variant often occurs in association with neoexpression of cytokeratins, which does not occur as often in the non-COL variants of FSGS. Cytokeratins are intermediate filaments present in most epithelial cells and composed of two pairs of keratin polypeptides, with each pair comprising a basic (Type II) and an acidic (Type I) CK. The lowmolecular-weight CKs 8, 18 and 19 are widely expressed in simple, ductal and pseudostratified epithelium throughout the human body [28] . They are expressed in podocytes during embryogenesis, but not in mature podocytes [29, 30] . Ultrastructural and immunohistochemical studies suggest that COL FSGS is a disease of primary podocyte injury, and that the cells that proliferate and fill Bowman's space in this variant, forming pseudocrescents, are dedifferentiated podocytes, although the origin of the cells that form the pseudocrescents is still controversial [16] . Several authors believe they are derived from parietal cells, as they express proteins characteristic of the latter (such as CK) and bridge with the parietal cells that coat Bowman's capsule in injured glomerular segments [7, 30, 31] . There is contestation to this hypothesis, as bridges between parietal cells and podocyte cells are also found in normal glomeruli [32] . In our opinion, both mechanisms might play a role in pseudocrescent formation. Testing for the cell proliferation marker Ki-67 in podocytes was positive in 18 of our cases: 10 COL, 3 NOS, 2 CEL and 3 TIP. Although this finding was apparently predominant in the COL variant, the difference was not statistically significant (P = 0.098) on comparison of the COL versus non-COL groups. Immunohistochemical expression of the Ki-67 antigen is associated with DNA synthesis, which characterizes entry into the S phase of the cell cycle. During the embryonic stage, healthy podocytes divide normally, but as they mature and differentiate they leave the cell cycle and enter a quiescent adult state. Shankland et al. (2000) showed that Ki-67 is expressed in glomerular injury caused by COL FSGS and HIVAN, but not in other podocyte diseases, such as MCD and GNM. Similar findings were reported by Barisoni et al. (1999) . As the CEL variant of FSGS is also regarded by some authors as a variant characterized by podocyte hyperplasia [18, 19] , we pooled cases of COL and CEL FSGS in our sample (Group 1) and compared them to NOS, TIP and PHI variant cases (Group 2). Ki-67 podocytes positivity occurred significantly more frequently in specimens from the Group 1 (P = 0.016).
There were no differences between FSGS variants in terms of expression of the pedicel cytoskeleton proteins synaptopodin and GLEPP-1 in our sample, although immunohistochemical analysis of both was hampered by the large number of inconclusive reactions due to technical difficulties.
Conclusion
In conclusion, 131 cases of primary FSGS analyzed, 38.2% were classified as variant NOS, 36.6% as COL, 14.5% as TIP, 6.9% PHI and 3.8% CEL according to the Columbia classification. This immunohistochemical study showed differences regarding podocyte differentiation and structural proteins in the variants of FSGS, which may have practical application. COL variant of FSGS distinguished itself from others in terms of immunohistochemical expression of podocyte markers in injured glomeruli as it showed a higher occurrence of loss of expression of CD10, α-actinin-4 and WT1. Variants also presented differences in immunoexpression of CK8-18 and CK19 in podocytes of glomerular lesions. The present study highlights the possible roles of immunohistochemistry in distinguishing FSGS variants based on podocyte markers; however, additional and complementary methods, as well as larger series, are required to validate these findings.
